Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer

Arthritis Rheumatol. 2017 Apr;69(4):687-699. doi: 10.1002/art.40043. Epub 2017 Mar 3.

Authors

Maria E Suarez-Almazor¹, Sang T Kim¹, Noha Abdel-Wahab², Adi Diab¹

Affiliations

¹ The University of Texas MD Anderson Cancer Center, Houston.
² The University of Texas MD Anderson Cancer Center, Houston, and Assiut University Hospitals, Assiut, Egypt.

PMID: 28085999
DOI: 10.1002/art.40043

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents, Immunological / adverse effects*
Antineoplastic Agents, Immunological / therapeutic use
CTLA-4 Antigen / antagonists & inhibitors*
Humans
Immunotherapy / adverse effects*
Neoplasms / drug therapy*
Neoplasms / immunology

Substances

Antineoplastic Agents, Immunological
CTLA-4 Antigen